PI3Kα-IN-14 is a selective PI3Kα inhibitor with an IC50 of 0.14 nM; it induces significant reduction of mitochondrial membrane potential, leading to G1 cell cycle arrest and apoptosis in U87-MG cells; it exhibits potent antiproliferative activity against three tumor-derived cell lines (PC-3: IC50 = 0.28 μM; HCT-116: IC50 = 0.57 μM; U87-MG: IC50 = 1.37 μM).